EXTON, Pa., Oct. 23, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Barcelona, Spain to showcase its leadership and expertise on industry challenges and trends in packaging and containment.
"West is applying its 100 years of innovation to address the changing containment and delivery needs of more complex molecules and combination products as well as more sustainable options for the industry," said Chris Ryan, Vice President, Containment and Glass Systems at West. "At this year's CPHI, West will be sharing our guidance on Annex 1 EU GMP regulations and, as the exclusive distributor of Corning® Viridian™ Vials, we will be introducing this product that brings both performance and sustainability to the industry."
West will highlight its industry expertise through several technical-focused presentations at its booth (2G40):
This year West is a finalist for the Drug Delivery Device category at the 2023 CPHI Pharma Awards for its FluroTec® 5-10mL Cartridge Plunger, the 13mm NovaPure® Ready to Use Stopper and the Flip-Off® CCS Seal combined offering to support large volume delivery. Corning® Viridian™ Vials were also announced as a finalist in the Sustainability category.
For more information about West, please visit our website: www.westpharma.com.
For more information about CPHI Worldwide, please visit: CPHI Barcelona | Where Business Meets Science
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year.
2023 marks West's 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
© 2023 West Pharmaceutical Services, Inc.
West and the diamond logo, FluroTec, Flip-Off, and NovaPure are registered trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
Corning® and Viridian™ are trademarks of Corning Incorporated.
West Pharmaceutical Services, Inc. is the exclusive distributor of Corning® Viridian™ Vials.
| Last Trade: | US$314.49 |
| Daily Change: | -23.63 -6.99 |
| Daily Volume: | 944,913 |
| Market Cap: | US$22.810B |
October 24, 2024 October 07, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
